Airway Management Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Airway Management Pipeline Market Report Overview

Airway management refers to medical procedures performed for the prevention or alleviation of any obstruction in the airway. These procedures are performed to open a pathway for maintaining or re-storing proper gas exchange between a patient’s lungs and the atmosphere. This is accomplished with the use of a supraglottic device (Endotracheal tubes) or supraglottic device (Laryngeal mask) or surgical method (Tracheostomy). The devices used for airway management are referred to as airway management devices. Airway management masks, airway management tubes, and intubation accessories are covered under this category.

The airway management pipeline market research report provides comprehensive information about the Airway Management pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Endotracheal Tubes

·       Tracheostomy Tubes

·       Intubation Accessories

·       Laryngeal Masks

·       Intubation Bougies

·       Airway Management Masks

·       Airway Management Tubes

·       Endotracheal Tube (ETT) Holders

Key Territories ·       The US

·       Europe

·       China

·       Australia

·       India

Key Regulatory Paths ·       510(k)

·       PMA

·       CE

·       NMPA

·       TGA

Leading Companies ·       Adroit USA, Inc

·       Airway Innovations LLC

·       All India Institute of Medical Sciences

·       Allvivo Vascular Inc

·       Avir Medical Pte Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Airway Management Pipeline Market by Segments

The key segments in the airway management market are Endotracheal Tubes, Tracheostomy Tubes, Intubation Accessories, Intubation Bougies, Laryngeal Masks, Airway Management Masks, Airway Management Tubes, and Endotracheal Tube (ETT) Holders. As of June 2023, the Endotracheal Tubes segment had the highest number of pipeline products.

Airway Management Pipeline Market Analysis by Segments, 2023 (%)

Airway Management Pipeline Market Analysis by Segments, 2023 (%)

For more segment insights into the Airway Management pipeline market, download a free report sample

Airway Management Pipeline Market Segmentation by Territories

Some of the key territories in the Airway Management market are the US, Europe, China, Australia, and India among others. As of June 2023, the US had the highest number of pipeline products.

Airway Management Pipeline Market Analysis by Territories, 2023 (%)

Airway Management Pipeline Market Analysis by Territories, 2023 (%)

For more territory insights into the Airway Management pipeline market, download a free report sample

Airway Management Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Airway Management pipeline market are 510(k), PMA, CE, NMPA, and TGA among others. As of June 2023, 510(k) was the most followed pathway for pipeline products.

Airway Management Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Airway Management Pipeline Market Analysis by Regulatory Paths, 2023 (%)

For more regulatory path insights into the Airway Management pipeline market, download a free report sample

Airway Management Pipeline Market – Competitive Landscape

Some of the key companies in the Airway Management pipeline market are Adroit USA, Airway Innovations LLC, All India Institute of Medical Sciences, Allvivo Vascular Inc, and Avir Medical Pte Ltd among others.

All India Institute of Medical Sciences Company Overview: All India Institute of Medical Sciences (AIIMS) is a medical institution that provides medical education, biomedical research, and healthcare services. It offers research services, teaching services, medical services, nursing services, and laboratory services among others. AIIMS conducts research in the field of neurosciences, genetics, and on computer simulation of hormone-receptor interaction. It applies DNA recombinant technology, immunology, and electron microscopy to study diseases such as leprosy, malaria, tuberculosis, diabetes, diarrhea, hepatitis, fluorosis, and iodine deficiency. AIIMS is headquartered in New Delhi, India.

Leading Airway Management Companies, 2023

Leading Airway Management Companies, 2023

For more company insights into the Airway Management pipeline market, download a free report sample

Segments Covered in the Report

Airway Management Pipeline Market Segments Outlook

  • Endotracheal Tubes
  • Tracheostomy Tubes
  • Intubation Accessories
  • Laryngeal Masks
  • Intubation Bougies
  • Airway Management Masks
  • Airway Management Tubes
  • Endotracheal Tube (ETT) Holders

Airway Management Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Australia
  • India

Airway Management Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • PMA
  • CE
  • NMPA
  • TGA

Scope

This report provides:

  • Extensive coverage of the Airway Management under development.
  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of Airway Management and lists of all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Airway Management under development.
  • Develop market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Actuated Medical Inc
ADM Tronics Unlimited Inc
Adroit USA, Inc
Airway Innovations LLC
All India Institute of Medical Sciences
Allvivo Vascular Inc
Avir Medical Pte Ltd
Baylor College of Medicine
BB Medical Surgical Inc
Ben-Gurion University of the Negev
Biovo Technologies Ltd
Bleep LLC
Brio Device, LLC
Cedars-Sinai Medical Center
Cognita Labs LLC
Columbia University
Cryofocus Medtech Shanghai Co Ltd
Daiichi Medical Co Ltd
DMF Medical Inc
Down From The Door LLC
Drexel University
Emory University
Enox Biopharma Inc (Inactive)
Fogless International AB
Free Flow Medical Inc
Gala Therapeutics Inc
H. Lee Moffitt Cancer Center & Research Institute Inc
Hannover Medical School
Iasis Molecular Sciences Inc
Illumitube
ImThera Medical Inc
Indian Institute of Technology Guwahati
Innovations Unlimited LLC
Innovent Medical Solutions Ltd
Innovex Medical Co Ltd
Inspire Medical Systems Inc
Intumed Ltd.
Johns Hopkins University
Johns Hopkins University School of Medicine
Kaohsiung Medical University
KK Women's and Children's Hospital
Laval University
LifeServe Innovations, LLC
LifeTech Respiratory Technology Co Ltd
Lingua Flex LLC
LMA Optimizer BV
Lundquist
Magnets In Me Inc
Maisonneuve-Rosemont Hospital
Materialise NV
Medical Device Investments, Inc.
Miach Medical Innovations
Minnesota Health Solutions Corporation
N8 Medical LLC
Nanofiber Solutions LLC
NanoVibronix Inc
National University of Singapore
Naval Medical Research Center
Nevap, Inc
Ningbo Senscure Biotechnology Co Ltd
Novlead Biotechnology Co Ltd
Nyxoah SA
Olifant Medical Inc
Oventus Pty Ltd
Pneumocool LLC
ProSomnus Sleep Technologies Inc
RegenaGraft
Respiosa BV
Resultados y Calidad del Sistema Sanitario Publico de Andalucia
Rutgers The State University of New Jersey
Sanovas Inc
Securisyn Medical LLC
Sedana Medical AB
Sharklet Technologies Inc
Silmag SA
Sommetrics, Inc.
Somne LLC
Sonoma Pharmaceuticals Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stevens Institute of Technology
Suzhou Xinmai Medical Equipment Co Ltd
Swiftsure Innovations
Synchrony Medical
Teleflex Inc
The Chaim Sheba Medical Center
The Chinese University of Hong Kong
The University of British Columbia
Tufts University
Tutti Toot Ltd
U.S. Department of Defence
Uniformed Services University of the Health Sciences
Universitas Padjadjaran
University of California Irvine
University of Colorado
University of Florida
University of Illinois at Chicago
University of Michigan
University of Michigan Pediatric Device Consortium
University of Minnesota
University of Missouri
University of Nebraska
University of Pittsburgh
University of Regensburg
University of Saskatchewan
University of South Florida
University of Texas at San Antonio
University of Texas Health Science Center at Houston
University of Virginia
VA Long Beach Healthcare System
Vanderbilt University
Vanderbilt University Medical Center
Vida Medical Devices Inc
Vincent Medical Holdings Ltd
Virginia Commonwealth University
Vrije University Brussel
Wake Forest Baptist Medical Center
Walter Cantidio University Hospital
WynnVision LLC
Xhale Inc
Youyi Medical Instrument Co Ltd
Zennea Technologies

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 9

|1.2 List of Figures 19

2 Introduction 20

2.1 Airway Management Overview 20

3 Products under Development 22

3.1 Airway Management – Pipeline Products by Stage of Development 22

3.2 Airway Management – Pipeline Products by Segment 23

3.3 Airway Management – Pipeline Products by Territory 24

3.4 Airway Management – Pipeline Products by Regulatory Path 25

3.5 Airway Management – Pipeline Products by Estimated Approval Date 26

3.6 Airway Management – Ongoing Clinical Trials 27

4 Airway Management – Pipeline Products under Development by Companies 28

4.1 Airway Management Companies – Pipeline Products by Stage of Development 28

4.2 Airway Management – Pipeline Products by Stage of Development 33

5 Airway Management Companies and Product Overview 37

5.1 Actuated Medical Inc Company Overview 37

5.1.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.2 ADM Tronics Unlimited Inc Company Overview 39

5.2.1 ADM Tronics Unlimited Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.3 Adroit USA, Inc Company Overview 40

5.3.1 Adroit USA, Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.4 Airway Innovations LLC Company Overview 41

5.4.1 Airway Innovations LLC Pipeline Products & Ongoing Clinical Trials Overview 41

5.5 All India Institute of Medical Sciences Company Overview 42

5.5.1 All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 42

5.6 Allvivo Vascular Inc Company Overview 44

5.6.1 Allvivo Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.7 Avir Medical Pte Ltd Company Overview 45

5.7.1 Avir Medical Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

5.8 Baylor College of Medicine Company Overview 46

5.8.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 46

5.9 BB Medical Surgical Inc Company Overview 47

5.9.1 BB Medical Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.10 Ben-Gurion University of the Negev Company Overview 48

5.10.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 48

5.11 Biovo Technologies Ltd Company Overview 50

5.11.1 Biovo Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

5.12 Bleep LLC Company Overview 51

5.12.1 Bleep LLC Pipeline Products & Ongoing Clinical Trials Overview 51

5.13 Brio Device, LLC Company Overview 54

5.13.1 Brio Device, LLC Pipeline Products & Ongoing Clinical Trials Overview 54

5.14 Cedars-Sinai Medical Center Company Overview 55

5.14.1 Cedars-Sinai Medical Center Pipeline Products & Ongoing Clinical Trials Overview 55

5.15 Cognita Labs LLC Company Overview 56

5.15.1 Cognita Labs LLC Pipeline Products & Ongoing Clinical Trials Overview 56

5.16 Columbia University Company Overview 57

5.16.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 57

5.17 Cryofocus Medtech Shanghai Co Ltd Company Overview 58

5.17.1 Cryofocus Medtech Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.18 Daiichi Medical Co Ltd Company Overview 61

5.18.1 Daiichi Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

5.19 DMF Medical Inc Company Overview 62

5.19.1 DMF Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.20 Down From The Door LLC Company Overview 65

5.20.1 Down From The Door LLC Pipeline Products & Ongoing Clinical Trials Overview 65

5.21 Drexel University Company Overview 66

5.21.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 66

5.22 Emory University Company Overview 68

5.22.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 68

5.23 Enox Biopharma Inc (Inactive) Company Overview 69

5.23.1 Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 69

5.24 Fogless International AB Company Overview 70

5.24.1 Fogless International AB Pipeline Products & Ongoing Clinical Trials Overview 70

5.25 Free Flow Medical Inc Company Overview 71

5.25.1 Free Flow Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 71

5.26 Gala Therapeutics Inc Company Overview 72

5.26.1 Gala Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 72

5.27 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview 76

5.27.1 H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 76

5.28 Hannover Medical School Company Overview 77

5.28.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 77

5.29 Iasis Molecular Sciences Inc Company Overview 78

5.29.1 Iasis Molecular Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 78

5.30 Illumitube Company Overview 79

5.30.1 Illumitube Pipeline Products & Ongoing Clinical Trials Overview 79

5.31 ImThera Medical Inc Company Overview 80

5.31.1 ImThera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.32 Indian Institute of Technology Guwahati Company Overview 83

5.32.1 Indian Institute of Technology Guwahati Pipeline Products & Ongoing Clinical Trials Overview 83

5.33 Innovations Unlimited LLC Company Overview 84

5.33.1 Innovations Unlimited LLC Pipeline Products & Ongoing Clinical Trials Overview 84

5.34 Innovent Medical Solutions Ltd Company Overview 85

5.34.1 Innovent Medical Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 85

5.35 Innovex Medical Co Ltd Company Overview 87

5.35.1 Innovex Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 87

5.36 Inspire Medical Systems Inc Company Overview 88

5.36.1 Inspire Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 88

5.37 Intumed Ltd. Company Overview 91

5.37.1 Intumed Ltd. Pipeline Products & Ongoing Clinical Trials Overview 91

5.38 Johns Hopkins University Company Overview 92

5.38.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 92

5.39 Johns Hopkins University School of Medicine Company Overview 95

5.39.1 Johns Hopkins University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 95

5.40 Kaohsiung Medical University Company Overview 96

5.40.1 Kaohsiung Medical University Pipeline Products & Ongoing Clinical Trials Overview 96

5.41 KK Women’s and Children’s Hospital Company Overview 97

5.41.1 KK Women’s and Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 97

5.42 Laval University Company Overview 98

5.42.1 Laval University Pipeline Products & Ongoing Clinical Trials Overview 98

5.43 LifeServe Innovations, LLC Company Overview 99

5.43.1 LifeServe Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 99

5.44 LifeTech Respiratory Technology Co Ltd Company Overview 100

5.44.1 LifeTech Respiratory Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 100

5.45 Lingua Flex LLC Company Overview 103

5.45.1 Lingua Flex LLC Pipeline Products & Ongoing Clinical Trials Overview 103

5.46 LMA Optimizer BV Company Overview 106

5.46.1 LMA Optimizer BV Pipeline Products & Ongoing Clinical Trials Overview 106

5.47 Lundquist Company Overview 107

5.47.1 Lundquist Pipeline Products & Ongoing Clinical Trials Overview 107

5.48 Magnets In Me Inc Company Overview 109

5.48.1 Magnets In Me Inc Pipeline Products & Ongoing Clinical Trials Overview 109

5.49 Maisonneuve-Rosemont Hospital Company Overview 112

5.49.1 Maisonneuve-Rosemont Hospital Pipeline Products & Ongoing Clinical Trials Overview 112

5.50 Materialise NV Company Overview 115

5.50.1 Materialise NV Pipeline Products & Ongoing Clinical Trials Overview 115

5.51 Medical Device Investments, Inc. Company Overview 116

5.51.1 Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 116

5.52 Miach Medical Innovations Company Overview 119

5.52.1 Miach Medical Innovations Pipeline Products & Ongoing Clinical Trials Overview 119

5.53 Minnesota Health Solutions Corporation Company Overview 120

5.53.1 Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview 120

5.54 N8 Medical LLC Company Overview 122

5.54.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 122

5.55 Nanofiber Solutions LLC Company Overview 125

5.55.1 Nanofiber Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview 125

5.56 NanoVibronix Inc Company Overview 126

5.56.1 NanoVibronix Inc Pipeline Products & Ongoing Clinical Trials Overview 126

5.57 National University of Singapore Company Overview 127

5.57.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 127

5.58 Naval Medical Research Center Company Overview 128

5.58.1 Naval Medical Research Center Pipeline Products & Ongoing Clinical Trials Overview 128

5.59 Nevap, Inc Company Overview 129

5.59.1 Nevap, Inc Pipeline Products & Ongoing Clinical Trials Overview 129

5.60 Ningbo Senscure Biotechnology Co Ltd Company Overview 130

5.60.1 Ningbo Senscure Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 130

5.61 Novlead Biotechnology Co Ltd Company Overview 133

5.61.1 Novlead Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 133

5.62 Nyxoah SA Company Overview 134

5.62.1 Nyxoah SA Pipeline Products & Ongoing Clinical Trials Overview 134

5.63 Olifant Medical Inc Company Overview 140

5.63.1 Olifant Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 140

5.64 Oventus Pty Ltd Company Overview 141

5.64.1 Oventus Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 141

5.65 Pneumocool LLC Company Overview 144

5.65.1 Pneumocool LLC Pipeline Products & Ongoing Clinical Trials Overview 144

5.66 ProSomnus Sleep Technologies Inc Company Overview 147

5.66.1 ProSomnus Sleep Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 147

5.67 RegenaGraft Company Overview 150

5.67.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 150

5.68 Respiosa BV Company Overview 151

5.68.1 Respiosa BV Pipeline Products & Ongoing Clinical Trials Overview 151

5.69 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 152

5.69.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 152

5.70 Rutgers The State University of New Jersey Company Overview 153

5.70.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 153

5.71 Sanovas Inc Company Overview 154

5.71.1 Sanovas Inc Pipeline Products & Ongoing Clinical Trials Overview 154

5.72 Securisyn Medical LLC Company Overview 155

5.72.1 Securisyn Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 155

5.73 Sedana Medical AB Company Overview 156

5.73.1 Sedana Medical AB Pipeline Products & Ongoing Clinical Trials Overview 156

5.74 Sharklet Technologies Inc Company Overview 159

5.74.1 Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 159

5.75 Silmag SA Company Overview 160

5.75.1 Silmag SA Pipeline Products & Ongoing Clinical Trials Overview 160

5.76 Sommetrics, Inc. Company Overview 162

5.76.1 Sommetrics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 162

5.77 Somne LLC Company Overview 168

5.77.1 Somne LLC Pipeline Products & Ongoing Clinical Trials Overview 168

5.78 Sonoma Pharmaceuticals Inc Company Overview 169

5.78.1 Sonoma Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 169

5.79 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 170

5.79.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 170

5.80 Stevens Institute of Technology Company Overview 171

5.80.1 Stevens Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 171

5.81 Suzhou Xinmai Medical Equipment Co Ltd Company Overview 172

5.81.1 Suzhou Xinmai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 172

5.82 Swiftsure Innovations Company Overview 173

5.82.1 Swiftsure Innovations Pipeline Products & Ongoing Clinical Trials Overview 173

5.83 Synchrony Medical Company Overview 174

5.83.1 Synchrony Medical Pipeline Products & Ongoing Clinical Trials Overview 174

5.84 Teleflex Inc Company Overview 177

5.84.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 177

5.85 The Chaim Sheba Medical Center Company Overview 179

5.85.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 179

5.86 The Chinese University of Hong Kong Company Overview 180

5.86.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 180

5.87 The University of British Columbia Company Overview 181

5.87.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 181

5.88 Tufts University Company Overview 182

5.88.1 Tufts University Pipeline Products & Ongoing Clinical Trials Overview 182

5.89 Tutti Toot Ltd Company Overview 183

5.89.1 Tutti Toot Ltd Pipeline Products & Ongoing Clinical Trials Overview 183

5.90 U.S. Department of Defence Company Overview 184

5.90.1 U.S. Department of Defence Pipeline Products & Ongoing Clinical Trials Overview 184

5.91 Uniformed Services University of the Health Sciences Company Overview 185

5.91.1 Uniformed Services University of the Health Sciences Pipeline Products & Ongoing Clinical Trials Overview 185

5.92 Universitas Padjadjaran Company Overview 186

5.92.1 Universitas Padjadjaran Pipeline Products & Ongoing Clinical Trials Overview 186

5.93 University of California Irvine Company Overview 187

5.93.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 187

5.94 University of Colorado Company Overview 189

5.94.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 189

5.95 University of Florida Company Overview 190

5.95.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 190

5.96 University of Illinois at Chicago Company Overview 191

5.96.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 191

5.97 University of Michigan Company Overview 192

5.97.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 192

5.98 University of Michigan Pediatric Device Consortium Company Overview 197

5.98.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 197

5.99 University of Minnesota Company Overview 198

5.99.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 198

5.100 University of Missouri Company Overview 200

5.100.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 200

5.101 University of Nebraska Company Overview 201

5.101.1 University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview 201

5.102 University of Pittsburgh Company Overview 203

5.102.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 203

5.103 University of Regensburg Company Overview 204

5.103.1 University of Regensburg Pipeline Products & Ongoing Clinical Trials Overview 204

5.104 University of Saskatchewan Company Overview 205

5.104.1 University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview 205

5.105 University of South Florida Company Overview 206

5.105.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 206

5.106 University of Texas at San Antonio Company Overview 207

5.106.1 University of Texas at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 207

5.107 University of Texas Health Science Center at Houston Company Overview 208

5.107.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 208

5.108 University of Virginia Company Overview 210

5.108.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 210

5.109 VA Long Beach Healthcare System Company Overview 211

5.109.1 VA Long Beach Healthcare System Pipeline Products & Ongoing Clinical Trials Overview 211

5.110 Vanderbilt University Company Overview 212

5.110.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 212

5.111 Vanderbilt University Medical Center Company Overview 214

5.111.1 Vanderbilt University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 214

5.112 Vida Medical Devices Inc Company Overview 215

5.112.1 Vida Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 215

5.113 Vincent Medical Holdings Ltd Company Overview 217

5.113.1 Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 217

5.114 Virginia Commonwealth University Company Overview 218

5.114.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 218

5.115 Vrije University Brussel Company Overview 219

5.115.1 Vrije University Brussel Pipeline Products & Ongoing Clinical Trials Overview 219

5.116 Wake Forest Baptist Medical Center Company Overview 220

5.116.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview 220

5.117 Walter Cantidio University Hospital Company Overview 222

5.117.1 Walter Cantidio University Hospital Pipeline Products & Ongoing Clinical Trials Overview 222

5.118 WynnVision LLC Company Overview 223

5.118.1 WynnVision LLC Pipeline Products & Ongoing Clinical Trials Overview 223

5.119 Xhale Inc Company Overview 224

5.119.1 Xhale Inc Pipeline Products & Ongoing Clinical Trials Overview 224

5.120 Youyi Medical Instrument Co Ltd Company Overview 225

5.120.1 Youyi Medical Instrument Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 225

5.121 Zennea Technologies Company Overview 229

5.121.1 Zennea Technologies Pipeline Products & Ongoing Clinical Trials Overview 229

6 Airway Management- Recent Developments 230

6.1 May 15, 2023: Materialise to hold annual shareholders’ meeting on June 6, 2023 230

6.2 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 230

6.3 May 04, 2023: Teleflex reports first quarter financial results and full year 2023 outlook 230

6.4 May 04, 2023: Cardinal Health reports third quarter fiscal year 2023 results and raises fiscal year 2023 non-gaap eps guidance 232

6.5 Apr 27, 2023: Materialise announces new chief financial officer 234

6.6 Apr 26, 2023: Merit Medical reports results for first quarter March 31, 2023 234

6.7 Apr 20, 2023: Teleflex announces first quarter 2023 earnings conference call information 235

6.8 Apr 12, 2023: Medtronic has a layoff in California 235

6.9 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023 235

6.10 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 235

6.11 Feb 23, 2023: Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results 236

6.12 Feb 21, 2023: Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference 240

6.13 Feb 15, 2023: Owens & Minor Announces Fourth Quarter & Full Year 2022 Earnings Release Date and Conference Call 240

6.14 Feb 09, 2023: Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information 240

6.15 Feb 09, 2023: Oxford scientists develop test that can identify respiratory viruses within five minutes 241

6.16 Feb 07, 2023: Ambu Announces Interim Report For Q1 2022/23 241

6.17 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023 243

6.18 Feb 02, 2023: Cardinal Health Reports Second Quarter Fiscal Year 2023 Results and Raises Fiscal Year 2023 Non-GAAP EPS Guidance 244

6.19 Jan 31, 2023: Materialise to Report Fourth Quarter 2022 Earnings on Tuesday, February 14, 2023 245

6.20 Jan 31, 2023: Electromed Schedules its Second Quarter Fiscal 2023 Financial Results Conference Call for February 14, 2023 245

6.21 Jan 17, 2023: electroCore Announces Expected Record 4Q 2022 Revenue of $2.5M; Provides Business Update 246

6.22 Dec 19, 2022: Cardinal Health Names Aaron Alt Chief Financial Officer 246

6.23 Nov 23, 2022: Medtronic Reports Quarterly Earnings 247

6.24 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 247

6.25 Nov 15, 2022: Ambu Announces Annual Report 2021/22 253

6.26 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 253

6.27 Nov 04, 2022: Poly Medicure Announces Unaudited Standalone & Consolidated Financial Results for the Quarter Ended 0n 30th Sep. 2022 253

6.28 Oct 27, 2022: Teleflex Reports Third Quarter Financial Results And Full Year Outlook 253

6.29 Oct 27, 2022: Materialise Reports Third Quarter 2022 Results 254

6.30 Oct 25, 2022: Electromed Schedules its First Quarter Fiscal 2023 Financial Results Conference Call for November 8, 2022 at 5:00 p.m. PT 255

6.31 Oct 13, 2022: Teleflex Announces Third Quarter 2022 Earnings Conference Call Information 256

6.32 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022 256

6.33 Sep 20, 2022: Electrocore Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals 256

6.34 Sep 16, 2022: ADC appoints former Kano APC leader, Karaye caretaker chairman 257

6.35 Sep 08, 2022: Cardinal Health Announces Pharmaceutical Segment Organizational Changes 257

6.36 Sep 07, 2022: Medtronic to appear at September investor conferences 257

6.37 Aug 25, 2022: Ambu Interim Report For Q3 2021/22 257

6.38 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 259

6.39 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 262

6.40 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule 265

6.41 Aug 11, 2022: Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2022 265

6.42 Aug 04, 2022: electroCore Announces Record Second Quarter 2022 Financial Results 266

6.43 Aug 04, 2022: Poly Medicure announces Financial results For The Quarter Ended 30Th June 2022 268

6.44 Aug 03, 2022: Owens & Minor Reports Second Quarter 2022 Financial Results 269

6.45 Aug 03, 2022: Ambu Announces Preliminary results for Q3 2021/22, Full-year 2021/22 guidance 271

6.46 Aug 01, 2022: Cardinal Health Names Michelle Greene as Chief Information Officer 273

6.47 Jul 29, 2022: ProSomnus to host first annual ProSleep users conference 273

6.48 Jul 28, 2022: Materialise Reports Second Quarter 2022 Results 274

6.49 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022 275

6.50 Jul 19, 2022: Electromed to Participate in the Canaccord Genuity 42nd Annual Growth Conference 277

6.51 Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022 277

6.52 Jul 13, 2022: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results 277

6.53 Jul 12, 2022: Owens & Minor Elects Carissa Rollins to Board of Directors 279

7 Appendix 280

7.1 Methodology 280

7.2 About GlobalData 283

7.3 Contact Us 283

7.4 Disclaimer 283

Frequently asked questions

Airway Management Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Airway Management Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Airway Management Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Airway Management Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.